A digital program to help people living with HIV quit smoking
Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV
This study is testing a helpful online tool to support people living with HIV who want to quit smoking, using a friendly approach that understands their unique challenges.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-11031384 on NIH RePORTER |
What this research studies
This research focuses on developing and testing a digital therapeutic specifically designed to assist individuals living with HIV in quitting smoking. Given the high rates of tobacco use in this population, the study aims to create a tailored intervention that incorporates Acceptance and Commitment Therapy, which has shown promise in smoking cessation. Participants will engage with this digital tool, which is designed to be accessible and user-friendly, while also addressing the unique challenges faced by people living with HIV. The research will evaluate both the effectiveness of this intervention and the factors that influence its implementation in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who currently smoke and are seeking assistance to quit.
Not a fit: Patients who do not smoke or those who are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve smoking cessation rates among people living with HIV, leading to better overall health outcomes.
How similar studies have performed: While digital therapeutics for smoking cessation have been effective in the general population, this specific approach tailored for people living with HIV is novel and has not been extensively tested before.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Vilardaga, Roger — Wake Forest University Health Sciences
- Study coordinator: Vilardaga, Roger
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.